These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 17869448)

  • 21. A randomized, double-blind, placebo-controlled trial assessing the impact of dexamphetamine on fatigue in patients with advanced cancer.
    Auret KA; Schug SA; Bremner AP; Bulsara M
    J Pain Symptom Manage; 2009 Apr; 37(4):613-21. PubMed ID: 18790598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase III double-blind study of glutamine versus placebo for the prevention of acute diarrhea in patients receiving pelvic radiation therapy.
    Kozelsky TF; Meyers GE; Sloan JA; Shanahan TG; Dick SJ; Moore RL; Engeler GP; Frank AR; McKone TK; Urias RE; Pilepich MV; Novotny PJ; Martenson JA;
    J Clin Oncol; 2003 May; 21(9):1669-74. PubMed ID: 12721240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II, randomised, double-blind, placebo-controlled trial of methylphenidate for reduction of fatigue levels in patients with prostate cancer receiving LHRH-agonist therapy.
    Richard PO; Fleshner NE; Bhatt JR; Hersey KM; Chahin R; Alibhai SM
    BJU Int; 2015 Nov; 116(5):744-52. PubMed ID: 24684534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon-induced fatigue in patients with melanoma: a pilot study of exercise and methylphenidate.
    Schwartz AL; Thompson JA; Masood N
    Oncol Nurs Forum; 2002 Aug; 29(7):E85-90. PubMed ID: 12183762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group.
    ; Strasser F; Luftner D; Possinger K; Ernst G; Ruhstaller T; Meissner W; Ko YD; Schnelle M; Reif M; Cerny T
    J Clin Oncol; 2006 Jul; 24(21):3394-400. PubMed ID: 16849753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901.
    Ryu JK; Swann S; LeVeque F; Scarantino CW; Johnson D; Chen A; Fortin A; Pollock J; Kim H; Ang KK
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):643-50. PubMed ID: 17293228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modafinil for the treatment of hypersomnia associated with myotonic muscular dystrophy in adults: a multicenter, prospective, randomized, double-blind, placebo-controlled, 4-week trial.
    Orlikowski D; Chevret S; Quera-Salva MA; Laforêt P; Lofaso F; Verschueren A; Pouget J; Eymard B; Annane D
    Clin Ther; 2009 Aug; 31(8):1765-73. PubMed ID: 19808135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methylphenidate hydrochloride improves cognitive function in patients with advanced cancer and hypoactive delirium: a prospective clinical study.
    Gagnon B; Low G; Schreier G
    J Psychiatry Neurosci; 2005 Mar; 30(2):100-7. PubMed ID: 15798785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methylphenidate extended release (OROS MPH) for the treatment of antidepressant-related sexual dysfunction in patients with treatment-resistant depression: results from a 4-week, double-blind, placebo-controlled trial.
    Pae CU; Marks DM; Masand PS; Peindl K; Hooper-Wood C; Han C; Mannelli P; Ciccone P; Patkar AA
    Clin Neuropharmacol; 2009; 32(2):85-8. PubMed ID: 19512961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy.
    Roscoe JA; Morrow GR; Hickok JT; Mustian KM; Griggs JJ; Matteson SE; Bushunow P; Qazi R; Smith B
    Breast Cancer Res Treat; 2005 Feb; 89(3):243-9. PubMed ID: 15754122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Effect of Methylphenidate on Fatigue in Advanced Cancer: An Aggregated N-of-1 Trial.
    Mitchell GK; Hardy JR; Nikles CJ; Carmont SA; Senior HE; Schluter PJ; Good P; Currow DC
    J Pain Symptom Manage; 2015 Sep; 50(3):289-96. PubMed ID: 25896104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylphenidate Versus Placebo for Treating Fatigue in Patients With Advanced Cancer: Randomized, Double-Blind, Multicenter, Placebo-Controlled Trial.
    Stone PC; Minton O; Richardson A; Buckle P; Enayat ZE; Marston L; Freemantle N
    J Clin Oncol; 2024 Jul; 42(20):2382-2392. PubMed ID: 38757263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term effectiveness and safety of dexmethylphenidate extended-release capsules in adult ADHD.
    Adler LA; Spencer T; McGough JJ; Jiang H; Muniz R
    J Atten Disord; 2009 Mar; 12(5):449-59. PubMed ID: 19218542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pilot, randomized, modified, double-blind, placebo-controlled trial of acupuncture for cancer-related fatigue.
    Balk J; Day R; Rosenzweig M; Beriwal S
    J Soc Integr Oncol; 2009; 7(1):4-11. PubMed ID: 19476729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of methylphenidate on quality of life in children with both developmental coordination disorder and ADHD.
    Flapper BC; Schoemaker MM
    Dev Med Child Neurol; 2008 Apr; 50(4):294-9. PubMed ID: 18352997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial.
    Lizogub VG; Riley DS; Heger M
    Explore (NY); 2007; 3(6):573-84. PubMed ID: 18005909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized trial of modafinil for the treatment of fatigue and excessive daytime sleepiness in individuals with chronic traumatic brain injury.
    Jha A; Weintraub A; Allshouse A; Morey C; Cusick C; Kittelson J; Harrison-Felix C; Whiteneck G; Gerber D
    J Head Trauma Rehabil; 2008; 23(1):52-63. PubMed ID: 18219235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of reboxetine in the treatment of attention-deficit/hyperactivity disorder in boys with intolerance to methylphenidate: an open-label, 8-week, methylphenidate-controlled trial.
    Cohen-Yavin I; Yoran-Hegesh R; Strous RD; Kotler M; Weizman A; Spivak B
    Clin Neuropharmacol; 2009; 32(4):179-82. PubMed ID: 19644227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single dose of methylphenidate improves cognitive performance in multiple sclerosis patients with impaired attention process.
    Harel Y; Appleboim N; Lavie M; Achiron A
    J Neurol Sci; 2009 Jan; 276(1-2):38-40. PubMed ID: 18817930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute neurocognitive response to methylphenidate among survivors of childhood cancer: a randomized, double-blind, cross-over trial.
    Conklin HM; Khan RB; Reddick WE; Helton S; Brown R; Howard SC; Bonner M; Christensen R; Wu S; Xiong X; Mulhern RK
    J Pediatr Psychol; 2007 Oct; 32(9):1127-39. PubMed ID: 17569711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.